April 17, 2007Gut106 citationsOpen Access
Risks and benefits of biologic therapy for inflammatory bowel diseases
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
Methods of infant pulmonary function testing (IPFT) represent an important diagnostic tool for an assessment of chronic lung disease in infancy (CLDI). We assessed lung function in a cohort of children with a perinatal burden. We tested 74 infants and toddlers (birth weight 1.47±1.11kg mean±SD; body length at birth 30.8±16.3cm with CLDI. Age at testing was 1.38±0.69 (median 1.35) yrs; body weight 9.0±2.2kg, body length 76.0±9.7cm. The whole-body plethysmography (to measure FRCp and sReff), tidal breathing analysis (tPTEF%tE), baby resistance/compliance (specific Crs) and rapid thoraco-abdominal compression method (VmaxFRC) were performed. MS Baby Body, VIASYS, USA was used. Standard protocols 1 and proper reference values 2 were used. FRCp equals 115.3±41.2% pred (PReferences: 1Hammer J, Eber E (eds). Pediatric Pulmonary Function Testing, 2005, Basel, Karger. 2Hulskamp G et al: Am J Respir Crit Care Med 2003;168:1003-9. Supported by the project “Follow-up of children with perinatal burden” of EEA and Norway grants and by the grant NT/11444-5.
Cite This Study
Geert D’Haens (2007) studied this question.